A 5-year-old boy from rural Bihar presents with his father complaining of inability to see in the evening and difficulty recognizing faces in dim light for the past 4 weeks. On examination, the anterior segment appears normal under bright illumination, but the father reports the child bumps into objects at dusk. Dark adaptation testing shows prolonged recovery time. Fundoscopy is unremarkable. The child's diet consists mainly of rice and lentils with rare access to fruits or vegetables. What is the earliest clinical sign of vitamin A deficiency evident in this case?

Explanation

## Diagnosis: Vitamin A Deficiency — Stage XN (Night Blindness) **Key Point:** Night blindness is the **earliest clinical manifestation** of vitamin A deficiency and occurs before any visible conjunctival or corneal changes. It reflects impaired synthesis of rhodopsin (visual purple), the rod photopigment essential for low-light vision. **High-Yield:** In population-based screening for vitamin A deficiency in endemic areas, night blindness is the most sensitive early indicator. A history of difficulty seeing at dusk or inability to navigate in dim light should immediately raise suspicion for VAD, even when the anterior segment appears normal under bright light. ### Biochemistry: Why Night Blindness Occurs First **Vitamin A (Retinol) → Retinal (Retinaldehyde) → Rhodopsin Formation** 1. Vitamin A is converted to retinal in the retinal pigment epithelium (RPE) 2. Retinal combines with opsin to form **rhodopsin**, the visual pigment in rod photoreceptors 3. Rhodopsin is exquisitely sensitive to light and enables vision in low-illumination conditions 4. With depleted vitamin A stores, rhodopsin synthesis declines → rods become non-functional → night blindness 5. Rod dysfunction precedes cone dysfunction because cones require less vitamin A and are more resistant to deficiency **Clinical Pearl:** Dark adaptation testing (measuring time for visual threshold to improve in darkness) is prolonged in VAD because rod regeneration of rhodopsin is impaired. This is a sensitive functional test before structural changes appear. ### Timeline of Xerophthalmia Progression ```mermaid flowchart LR A["Stage XN<br/>Night Blindness<br/>(Earliest)"]:::outcome --> B["Stage X1A<br/>Conjunctival Xerosis"]:::outcome B --> C["Stage X1B<br/>Bitot's Spots"]:::outcome C --> D["Stage X2<br/>Corneal Xerosis/Haze"]:::outcome D --> E["Stage X3A<br/>Corneal Ulceration"]:::urgent E --> F["Stage XS<br/>Corneal Scar<br/>(Permanent Blindness)"]:::urgent G["Vitamin A Supplementation"]:::action -.->|Reverses if given early| B G -.->|Reverses if given early| C G -.->|Reverses if given early| D G -.->|May prevent progression| E G -.->|Cannot reverse| F ``` **Warning:** Parents often attribute night blindness to "normal childhood behavior" or dismiss it as the child being "timid in the dark." A careful history of specific inability to navigate or recognize people in dim light is the key diagnostic clue. ### WHO Diagnostic Criteria for Night Blindness (XN) - History of difficulty seeing in dim light or inability to navigate in darkness - Normal anterior segment on bright illumination - Prolonged dark adaptation time (>5 minutes to reach threshold) - **Reversible with vitamin A supplementation within days** **Mnemonic: ABCDE of Xerophthalmia** — **A** (night blindness/Adaptation defect), **B** (Bitot's spots), **C** (Corneal xerosis), **D** (corneal Defect), **E** (End-stage scar). ### Management of Stage XN - **Vitamin A 200,000 IU orally** on day 1, day 2, and day 15 (same as other stages) - Night blindness typically resolves within **3–7 days** of starting supplementation - Dietary counselling: increase vitamin A-rich foods (eggs, liver, dark leafy greens, orange vegetables) - No topical therapy needed at this stage - Prognosis: **100% reversible** if treated early